NCT02484807View on ClinicalTrials.gov

Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH

CompletedOBSERVATIONAL
Enrollment

125

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Pulmonary Arterial Hypertension
Interventions
OTHER

no intervention, only observation of different groups

Trial Locations (1)

69126

Centre for pulmonary hypertension, Thoraxclinic at the University Hospital Heidelberg, Heidelberg

All Listed Sponsors
lead

Heidelberg University

OTHER

NCT02484807 - Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH | Biotech Hunter | Biotech Hunter